EP1051624A4 - Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers - Google Patents

Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers

Info

Publication number
EP1051624A4
EP1051624A4 EP99902461A EP99902461A EP1051624A4 EP 1051624 A4 EP1051624 A4 EP 1051624A4 EP 99902461 A EP99902461 A EP 99902461A EP 99902461 A EP99902461 A EP 99902461A EP 1051624 A4 EP1051624 A4 EP 1051624A4
Authority
EP
European Patent Office
Prior art keywords
methods
high density
density arrays
proteome analysis
compositions therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99902461A
Other languages
German (de)
English (en)
Other versions
EP1051624A1 (fr
Inventor
Ian Humphery-Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaucus Proteomics BV
Original Assignee
Glaucus Proteomics BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaucus Proteomics BV filed Critical Glaucus Proteomics BV
Publication of EP1051624A1 publication Critical patent/EP1051624A1/fr
Publication of EP1051624A4 publication Critical patent/EP1051624A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00279—Features relating to reactor vessels
    • B01J2219/00306—Reactor vessels in a multiple arrangement
    • B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315—Microtiter plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/0054—Means for coding or tagging the apparatus or the reagents
    • B01J2219/00547—Bar codes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/0061—The surface being organic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614—Delimitation of the attachment areas
    • B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00623—Immobilisation or binding
    • B01J2219/00626—Covalent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00623—Immobilisation or binding
    • B01J2219/0063—Other, e.g. van der Waals forces, hydrogen bonding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00659—Two-dimensional arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00725—Peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP99902461A 1998-01-29 1999-01-29 Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers Withdrawn EP1051624A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7296198P 1998-01-29 1998-01-29
US72961P 1998-01-29
PCT/AU1999/000060 WO1999039210A1 (fr) 1998-01-29 1999-01-29 Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers

Publications (2)

Publication Number Publication Date
EP1051624A1 EP1051624A1 (fr) 2000-11-15
EP1051624A4 true EP1051624A4 (fr) 2002-05-02

Family

ID=22110842

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99902461A Withdrawn EP1051624A4 (fr) 1998-01-29 1999-01-29 Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers

Country Status (5)

Country Link
EP (1) EP1051624A4 (fr)
JP (1) JP2002502038A (fr)
AU (1) AU740830B2 (fr)
CA (1) CA2319828A1 (fr)
WO (1) WO1999039210A1 (fr)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002502977A (ja) 1998-02-04 2002-01-29 インビトロジェン コーポレイション マイクロアレイとその使用
GB9816514D0 (en) * 1998-07-29 1998-09-30 Smithkline Beecham Plc Novel method
JP2002532066A (ja) 1998-11-16 2002-10-02 ジェンウェイ バイオテック， インコーポレイテッド 鳥類におけるポリヌクレオチドワクチンを用いる抗体の産生
DK2230303T3 (da) * 1999-05-05 2013-04-15 Phylogica Ltd Isolering af biologiske modulatorer fra biodiverse genfragment-biblioteker
GB9928787D0 (en) * 1999-12-03 2000-02-02 Medical Res Council Direct screening method
GB9928789D0 (en) * 1999-12-03 2000-02-02 Medical Res Council Naive screening method
US7816098B2 (en) 2000-01-31 2010-10-19 Sense Proteomic Limited Methods of making and using a protein array
JP4730804B2 (ja) * 2000-01-31 2011-07-20 センス・プロテオミック・リミテッド 方法
AU3037501A (en) * 2000-01-31 2001-08-14 Sense Proteomic Limited Methods
EP1285092A4 (fr) 2000-04-14 2003-07-16 Metabolon Inc Procedes permettant de decouvrir des medicaments, de traiter des maladies et de poser des diagnostics a l'aide de la metabolomique
JP2004511753A (ja) * 2000-05-04 2004-04-15 イエール　ユニバーシティー タンパク質活性のスクリーニング用タンパク質チップ
DE10023130B4 (de) * 2000-05-11 2007-10-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Hyphenspezifische Faktoren aus Candida albicans
US20020115068A1 (en) * 2000-06-23 2002-08-22 Ian Tomlinson Matrix screening method
EP1301632A2 (fr) * 2000-07-19 2003-04-16 Pointilliste, Inc. Tri a plusieurs niveaux et le criblage a grande capacite
IL137460A0 (en) * 2000-07-24 2001-07-24 Yeda Res & Dev Identifying antigen clusters for monitoring a global state of an immune system
US20020048823A1 (en) * 2000-08-11 2002-04-25 Qianjin Hu Methods and universal monoclonal antibody array
JP2004509645A (ja) * 2000-08-17 2004-04-02 センス・プロテオミック・リミテッド 方法
US7094568B2 (en) 2000-08-17 2006-08-22 Sense Proteomic Ltd. Method for producing proteins tagged at the N- or C-terminus
WO2002025288A2 (fr) * 2000-09-22 2002-03-28 Clontech Laboratories Inc. Procedes d'analyse proteomique a haute sensibilite, trousses et systemes utiles pour mettre en oeuvre ces derniers
DE10054055A1 (de) 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
WO2002039120A1 (fr) * 2000-11-09 2002-05-16 Bionova Pharmaceutials, Inc. Procede d'identification du proteome de cellules utilisant un microreseau de banques d'anticorps
US6905816B2 (en) 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
WO2002046754A2 (fr) * 2000-12-08 2002-06-13 Neuronz Limited Proteomique fonctionnelle mettant en oeuvre un double criblage avec expression a la surface de phages
ATE513854T1 (de) * 2000-12-13 2011-07-15 Bac Ip B V Proteinraster aus variablen domänen der schweren immunoglobulinkette von kamelen
AU2002231028B2 (en) 2000-12-14 2008-01-31 Paul Stroobant Differential phage capture proteomics
DE10100122A1 (de) * 2001-01-03 2002-07-11 Henkel Kgaa Verfahren zur Bestimmung der Hautalterung in vitro
US7214498B2 (en) 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
CA2443777A1 (fr) * 2001-04-10 2002-10-24 The Board Of Trustees Of The Leland Stanford Junior University Utilisation therapeutique et diagnostique de profils de specificite d'anticorps
WO2002084296A2 (fr) * 2001-04-14 2002-10-24 Aplagen Gmbh Procede de selection de molecules de liaison immunologiques
EP1249704A1 (fr) * 2001-04-14 2002-10-16 Frank, Hans-Georg c/o Lehrstuhl für Anatomie II Universitätsklinikum der RWTH Procédé de selection des molecules liant immunologiques
WO2002092118A1 (fr) * 2001-05-11 2002-11-21 Yale University Analyse globale d'activites proteiques au moyen de puces proteomiques
EP1401808B1 (fr) 2001-05-24 2009-07-08 Neuren Pharmaceuticals Limited Peptidomimetiques et analogues de gpe
US7714020B2 (en) 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
US7605177B2 (en) 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
US7863004B2 (en) * 2001-12-04 2011-01-04 Wayne State University Neoepitope detection of disease using protein arrays
EP1319954A1 (fr) * 2001-12-12 2003-06-18 Centre National de Genotypage Methodes d'analyse des protéines qui utilisent des reseaux de capture
US20030228709A1 (en) * 2002-03-25 2003-12-11 Kozlowski Roland Zbignieiw Arrays
WO2004046164A2 (fr) * 2002-05-10 2004-06-03 Engeneos, Inc. Sequences de reconnaissance uniques et leurs procedes d'utilisation dans l'analyse de proteines
US7618788B2 (en) 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US7460960B2 (en) 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
CA2490522A1 (fr) * 2002-06-20 2003-12-31 Paul Stroobant Procedes ameliores appliques a la proteomique par capture differentielle
US7252954B2 (en) * 2002-10-15 2007-08-07 Abmetrix, Inc. Sets of digital antibodies directed against short epitopes, and methods using same
GB0305448D0 (en) * 2003-03-10 2003-04-16 Tcp Innovations Ltd Immunoassay
US20050208519A1 (en) * 2004-03-12 2005-09-22 Genenews Inc. Biomarkers for diagnosing schizophrenia and bipolar disorder
EP2270034A3 (fr) 2004-06-03 2011-06-01 Athlomics Pty Ltd Agents et procédé permettant le diagnostic de stress
EP1910565A4 (fr) 2005-07-07 2009-10-28 Athlomics Pty Ltd Gènes à polynucléotides marqueurs et leur expression dans le diagnostique de l'endotoxémie
CA2638912A1 (fr) 2006-02-20 2007-08-30 Phylogica Limited Procede de construction et de criblage de bibliotheques de structures peptidiques
US7855057B2 (en) 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
JP2009543862A (ja) 2006-07-14 2009-12-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ガンのバイオマーカーおよびその使用方法
WO2008147345A2 (fr) * 2006-11-13 2008-12-04 George Dacai Liu Système et procédé pour la détection indépendante de la structure d'antigène d'antigènes capturés sur des matrices d'anticorps
DK3255146T3 (da) 2009-03-16 2019-08-19 Pangu Biopharma Ltd Præparater og fremgangsmåder omfattende histidyl-tRNA-synthetasesplejsningsvarianter med ikke-kanoniske biologiske aktiviteter
US20100310576A1 (en) 2009-03-31 2010-12-09 Adams Ryan A COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
US8980253B2 (en) 2010-04-26 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
US20120003639A1 (en) 2010-04-27 2012-01-05 Prelude, Inc. Cancer biomarkers and methods of use thereof
CN103096911B (zh) 2010-04-27 2018-05-29 Atyr 医药公司 与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
AU2011248489B2 (en) 2010-04-28 2016-10-06 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases
WO2011150279A2 (fr) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps liées à fragments protéiques de glutaminyl-arnt synthétases
CN103097523B (zh) 2010-04-29 2016-09-28 Atyr医药公司 与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
EP2563383B1 (fr) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Découverte innovatrice de compositions thérapeutiques, diagnostiques, et d'anticorps associées aux fragments protéiques des valyle arnt synthétases
CA2800557A1 (fr) 2010-04-29 2011-11-03 Medical Prognosis Institute A/S Methodes et dispositifs permettant de predire l'efficacite d'un traitement
CA2797277C (fr) 2010-05-03 2021-02-23 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, de diagnostic et d'anticorps liees a des fragments proteiques d'arginyle-arnt synthetases
EP2566496B1 (fr) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, diagnostiques et à base d'anticorps liées des fragments protéiques de méthionyl-arnt-synthétases
US9034321B2 (en) 2010-05-03 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
CA2798139C (fr) 2010-05-04 2019-09-24 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, diagnostiques et a base d'anticorps liees a des fragments proteiques de complexe multi-arnt synthetase p38
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CN103096914B (zh) 2010-05-17 2015-08-12 Atyr医药公司 与亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
AU2011261486B2 (en) 2010-06-01 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases
WO2011159959A2 (fr) * 2010-06-16 2011-12-22 Cdi Laboratories Procédés et systèmes permettant de générer, de valider et d'utiliser des anticorps monoclonaux
EP2593125B1 (fr) 2010-07-12 2017-11-01 aTyr Pharma, Inc. DÉCOUVERTE INNOVANTE DE COMPOSITIONS THÉRAPEUTIQUES, DE DIAGNOSTIC ET D'ANTICORPS SE RAPPORTANT À DES FRAGMENTS PROTÉIQUES DE GLYCYL-ARNt SYNTHÉTASES
CN103108650A (zh) 2010-08-25 2013-05-15 Atyr医药公司 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
EP2714927B1 (fr) 2011-06-01 2016-08-10 Medical Prognosis Institute A/S Procédés et dispositifs pour le pronostic d'une rechute du cancer
KR20140123571A (ko) 2012-02-16 2014-10-22 에이티와이알 파마, 인코포레이티드 자가면역 및 염증성 질환의 치료를 위한 히스티딜­ｔｒｎａ 신테타제
WO2014085434A1 (fr) 2012-11-27 2014-06-05 Pontificia Universidad Catolica De Chile Compositions et procédés de diagnostic de tumeurs de la thyroïde
WO2014195032A1 (fr) 2013-06-07 2014-12-11 Medical Prognosis Institute A/S Procédés et dispositifs pour prédire une efficacité de traitement de fulvestrant chez des patients atteints de cancer
JP2017503169A (ja) 2013-12-31 2017-01-26 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド オリゴヌクレオチド抗原を使用する全身性エリテマトーデスの診断
EP3169815B1 (fr) 2014-07-15 2020-12-23 Ontario Institute For Cancer Research Procédés et dispositifs permettant de prédire l'efficacité d'un traitement à l'anthracycline
US11543411B2 (en) 2014-12-05 2023-01-03 Prelude Corporation DCIS recurrence and invasive breast cancer
WO2016139659A1 (fr) 2015-03-01 2016-09-09 Immunarray Ltd. Diagnostic du lupus érythémateux systémique à l'aide d'antigènes protéiques, peptidiques et oligonucléotidiques
US11884978B2 (en) 2015-09-30 2024-01-30 Immunexpress Pty Ltd Pathogen biomarkers and uses therefor
EP3394291B1 (fr) 2015-12-24 2021-10-06 Immunexpress Pty Ltd Biomarqueurs de triage et utilisations correspondantes
JP7371019B2 (ja) 2018-05-10 2023-10-30 ザ・メソジスト・ホスピタル 疾病の予後と管理のための方法
WO2020056338A1 (fr) 2018-09-14 2020-03-19 Prelude Corporation Méthode de sélection pour le traitement d'individus présentant un risque de cancer du sein invasif
JP2022551918A (ja) * 2019-10-09 2022-12-14 エドワード フリッチュ， マルチドメインタンパク質ワクチン

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829010A (en) * 1987-03-13 1989-05-09 Tanox Biosystems, Inc. Immunoassay device enclosing matrixes of antibody spots for cell determinations
WO1999040434A1 (fr) * 1998-02-04 1999-08-12 Invitrogen Corporation Microsystemes et leurs mises en application
WO2000004389A2 (fr) * 1998-07-14 2000-01-27 Zyomyx, Inc. Groupements d'agents d'interception de proteine et procedes d'utilisation de ceux-ci
WO2000039580A1 (fr) * 1998-12-23 2000-07-06 University Of Sydney Essai pour la detection d'un partenaire de liaison

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR231590A1 (es) * 1981-04-29 1984-12-28 Ciba Geigy Ag Dispositivo de analisis inmunologico y procedimiento para obtenerlo
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
GB9207086D0 (en) * 1992-03-31 1992-05-13 Sharp Kk Improvements relating to information technology
AU4770296A (en) * 1995-03-27 1996-10-16 Warner-Lambert Company Method and apparatus for simultaneously testing a plurality of compounds to detect their activity
JPH1025299A (ja) * 1996-07-12 1998-01-27 Nec Corp 整列ペプチド、及びそれを用いたタンパク質の結合・相互作用部位検出方法
US5763158A (en) * 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
AU7164998A (en) * 1997-04-28 1998-11-24 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829010A (en) * 1987-03-13 1989-05-09 Tanox Biosystems, Inc. Immunoassay device enclosing matrixes of antibody spots for cell determinations
WO1999040434A1 (fr) * 1998-02-04 1999-08-12 Invitrogen Corporation Microsystemes et leurs mises en application
WO2000004389A2 (fr) * 1998-07-14 2000-01-27 Zyomyx, Inc. Groupements d'agents d'interception de proteine et procedes d'utilisation de ceux-ci
WO2000039580A1 (fr) * 1998-12-23 2000-07-06 University Of Sydney Essai pour la detection d'un partenaire de liaison

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9939210A1 *

Also Published As

Publication number Publication date
EP1051624A1 (fr) 2000-11-15
WO1999039210A1 (fr) 1999-08-05
AU2259799A (en) 1999-08-16
JP2002502038A (ja) 2002-01-22
CA2319828A1 (fr) 1999-08-05
AU740830B2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
EP1051624A4 (fr) Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers
GB2339279B (en) Mutation analysis using mass spectrometry
IL141308A0 (en) Methods, instruments and materials for chondrocyte cell transplantation
EP1108216A4 (fr) Station de sondage analytique haute resolution
AU2024700A (en) (in situ) method of analyzing cells
GB9920280D0 (en) Mass spectrometer
IL124556A0 (en) I/o toggle test method using jtag
HUP0200219A3 (en) Nuclear resistance cell and methods for making same
EP1100966A4 (fr) Procede d'analyse in situ de cellules
AU2884499A (en) Selective cell analysis
GB2334101B (en) Method of analyzing substances existing in gas
GB9803425D0 (en) Microtome
GB2361101B (en) Data analysis
AU2869599A (en) Cell analysis methods and apparatus
AU1985200A (en) Analysis method and analyzer
GB9814420D0 (en) Sequence analysis of saccharide material
GB2377931B (en) Low density materials
GB2335037B (en) Sample diluter
GB2340125B (en) Low density materials
AUPP541998A0 (en) Density analysis
GB9804780D0 (en) Microtome
GB9827903D0 (en) Sample analysis
GB2340940B (en) Sample collection
EP1060377A4 (fr) Reactifs et methodes de microsequen age de proteines
GB9804644D0 (en) Sample diluter

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000727

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GLAUCUS PROTEOMICS B.V.

A4 Supplementary search report drawn up and despatched

Effective date: 20020319

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/68 A, 7G 01N 33/53 B, 7C 07K 1/04 B

111Z Information provided on other rights and legal means of execution

Free format text: 20020724 AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040803